121 related articles for article (PubMed ID: 17128593)
1. [A comparison of inhalatory beta2-mimetics with long-term action (formoterol vs. salmeterol)].
Kollár P; Kotolová H
Ceska Slov Farm; 2006 Sep; 55(5):230-5. PubMed ID: 17128593
[TBL] [Abstract][Full Text] [Related]
2. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological similarities and differences between beta2-agonists.
Lötvall J
Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
Buchwald A; Hochhaus G
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
[TBL] [Abstract][Full Text] [Related]
7. [Beta-agonists: new perspective in the treatment of asthma?].
Quadrelli SA; Roncoroni AJ; Pinna DM
Medicina (B Aires); 1999; 59(3):293-9. PubMed ID: 10451572
[TBL] [Abstract][Full Text] [Related]
8. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
9. Choosing a bronchodilator for asthma therapy: the role of rapid onset of action.
Nightingale CH
Adv Ther; 1994; 11(2):78-84. PubMed ID: 10147147
[TBL] [Abstract][Full Text] [Related]
10. Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol.
Santus P; Radovanovic D; Paggiaro P; Papi A; Sanduzzi A; Scichilone N; Braido F
Eur J Intern Med; 2015 Jul; 26(6):379-84. PubMed ID: 26049917
[TBL] [Abstract][Full Text] [Related]
11. Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
Lindmark B
Ther Adv Respir Dis; 2008 Oct; 2(5):279-99. PubMed ID: 19124378
[TBL] [Abstract][Full Text] [Related]
12. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
[TBL] [Abstract][Full Text] [Related]
13. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
14. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
Miyagawa T
Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
[TBL] [Abstract][Full Text] [Related]
15. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Kobayashi Y; Yasuba H; Kudou M; Kita H
J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol: a long acting bronchodilator.
Bhadoria DP; Bhadoria P
J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700
[No Abstract] [Full Text] [Related]
17. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
[TBL] [Abstract][Full Text] [Related]
19. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[TBL] [Abstract][Full Text] [Related]
20. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
